Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A summary risk score for the prediction of Alzheimer disease in elderly persons.

Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA.

Arch Neurol. 2010 Jul;67(7):835-41. doi: 10.1001/archneurol.2010.136.

2.

Accuracy of summary risk score for prediction of Alzheimer disease: better than demographics alone?

Barnes DE, Yaffe K.

Arch Neurol. 2011 Feb;68(2):268; author reply 268-70. doi: 10.1001/archneurol.2011.4. No abstract available.

PMID:
21321000
3.

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.

Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ.

Arch Neurol. 2008 Jan;65(1):89-93. doi: 10.1001/archneurol.2007.29.

PMID:
18195144
4.

Vascular risk scores for dementia: age matters.

Reijmer Y, Biessels GJ.

Arch Neurol. 2011 Feb;68(2):267; author reply 268-70. doi: 10.1001/archneurol.2011.2. No abstract available.

PMID:
21320999
5.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
6.

Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.

Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.

Arch Neurol. 2006 Nov;63(11):1586-90.

PMID:
17101827
7.

How can elderly apolipoprotein E ε4 carriers remain free from dementia?

Ferrari C, Xu WL, Wang HX, Winblad B, Sorbi S, Qiu C, Fratiglioni L.

Neurobiol Aging. 2013 Jan;34(1):13-21. doi: 10.1016/j.neurobiolaging.2012.03.003. Epub 2012 Apr 11.

PMID:
22503000
8.

The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.

Tosto G, Bird TD, Bennett DA, Boeve BF, Brickman AM, Cruchaga C, Faber K, Foroud TM, Farlow M, Goate AM, Graff-Radford NR, Lantigua R, Manly J, Ottman R, Rosenberg R, Schaid DJ, Schupf N, Stern Y, Sweet RA, Mayeux R; National Institute on Aging Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) Family Study Group.

JAMA Neurol. 2016 Oct 1;73(10):1231-1237. doi: 10.1001/jamaneurol.2016.2539.

9.

Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.

Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA.

JAMA Neurol. 2013 Dec;70(12):1544-51. doi: 10.1001/jamaneurol.2013.4215.

10.

Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.

Chouraki V, Reitz C, Maury F, Bis JC, Bellenguez C, Yu L, Jakobsdottir J, Mukherjee S, Adams HH, Choi SH, Larson EB, Fitzpatrick A, Uitterlinden AG, de Jager PL, Hofman A, Gudnason V, Vardarajan B, Ibrahim-Verbaas C, van der Lee SJ, Lopez O, Dartigues JF, Berr C, Amouyel P, Bennett DA, van Duijn C, DeStefano AL, Launer LJ, Ikram MA, Crane PK, Lambert JC, Mayeux R, Seshadri S; International Genomics of Alzheimer’s Project.

J Alzheimers Dis. 2016 Jun 18;53(3):921-32. doi: 10.3233/JAD-150749.

11.

The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Berry-Kravis E, Bennett DA.

Neurocase. 2005 Feb;11(1):3-7.

PMID:
15804918
12.

Central obesity in the elderly is related to late-onset Alzheimer disease.

Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):101-5. doi: 10.1097/WAD.0b013e318222f0d4.

13.

Physical activity, diet, and risk of Alzheimer disease.

Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, Stern Y.

JAMA. 2009 Aug 12;302(6):627-37. doi: 10.1001/jama.2009.1144.

14.

Depressive symptoms, vascular risk factors, and Alzheimer's disease.

Luchsinger JA, Honig LS, Tang MX, Devanand DP.

Int J Geriatr Psychiatry. 2008 Sep;23(9):922-8. doi: 10.1002/gps.2006.

15.

Relation of diabetes to mild cognitive impairment.

Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R.

Arch Neurol. 2007 Apr;64(4):570-5.

PMID:
17420320
16.

Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study.

Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K.

Mov Disord. 2002 Mar;17(2):250-7.

PMID:
11921109
17.

Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA).

Vardarajan BN, Faber KM, Bird TD, Bennett DA, Rosenberg R, Boeve BF, Graff-Radford NR, Goate AM, Farlow M, Sweet RA, Lantigua R, Medrano MZ, Ottman R, Schaid DJ, Foroud TM, Mayeux R; NIA-LOAD/NCRAD Family Study Group.

JAMA Neurol. 2014 Mar;71(3):315-23. doi: 10.1001/jamaneurol.2013.5570.

18.

Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.

Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D; AIBL Research Group.

Brain. 2013 Jul;136(Pt 7):2201-16. doi: 10.1093/brain/awt127. Epub 2013 Jun 3.

PMID:
23737466
19.

Type 2 diabetes and late-onset Alzheimer's disease.

Cheng D, Noble J, Tang MX, Schupf N, Mayeux R, Luchsinger JA.

Dement Geriatr Cogn Disord. 2011;31(6):424-30. doi: 10.1159/000324134. Epub 2011 Jul 15.

20.

Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties.

Rabin LA, Wang C, Katz MJ, Derby CA, Buschke H, Lipton RB.

J Am Geriatr Soc. 2012 Jun;60(6):1128-34. doi: 10.1111/j.1532-5415.2012.03956.x.

Supplemental Content

Support Center